Lehrstuhl für Haut- und Geschlechtskrankheiten

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort (2022) Simon D, Tascilar K, Kleyer A, Fagni F, Krönke G, Meder C, Dietrich P, et al. Journal article Tebentafusp als neuartige Immuntherapie zeigt einen Überlebensvorteil beim metastasierten Uveamelanom und wird bereits in Deutschland eingesetzt. (2022) Hassel JC, Berking C Journal article Alzheimer's disease protease-containing plasma extracellular vesicles transfer to the hippocampus via the choroid plexus (2022) Lee JH, Ostalecki C, Oberstein T, Schierer S, Zinser E, Eberhardt M, Blume K, et al. Journal article A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma (2022) Koch E, Schaft N, Kummer M, Berking C, Schuler G, Hasumi K, Dörrie J, Schuler-Thurner B Journal article Multi-Level Computational Modeling of Anti-Cancer Dendritic Cell Vaccination Utilized to Select Molecular Targets for Therapy Optimization (2022) Lai X, Keller C, Santos Rosales G, Schaft N, Dörrie J, Vera J Journal article Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry (2022) Stoelzl D, Boraczynski N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, et al. Conference contribution Select hyperactivating NLRP3 ligands enhance the TH1-and TH17-inducing potential of human type 2 conventional dendritic cells (2022) Heger L, Hatscher L, Lehmann C, Purbojo A, Onderka C, Liang C, Hartmann A, et al. Conference contribution Soluble CD83 promotes cutaneous wound healing in an IDO-and beta-catenindependent manner (2022) Royzman D, Peckert-Maier K, Stich L, Wild A, Ostalecki C, Kiesewetter F, Seyferth S, et al. Conference contribution Nectin-1 determines the susceptibility of malignant melanoma to oncolytic herpes simplex virus in vitro and in vivo (2022) Schwertner B, Lindner G, Stauner CT, Klapproth E, Magnus C, Rohrhofer A, Gross S, et al. Conference contribution Dissecting the IFN gamma-mediated transcriptomic alterations in Merkel cell carcinoma cell lines using Nanopore sequencing (2022) Sauerer T, Lischer C, Berking C, Vera González J, Dörrie J Conference contribution